Document Detail


The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--I. Effects of K(+)-depolarization, lesions and peptidase inhibition.
MedLine Citation:
PMID:  7891855     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Extracellular levels of dynorphin B were analysed with in vivo microdialysis in the neostriatum and substantia nigra of halothane-anaesthetized rats. Dopamine and its metabolites, 3,4-dihydroxyphenyl-acetic acid and homovanillic acid, as well as GABA were simultaneously monitored. Chromatographic analysis revealed that the dynorphin B-like immunoreactivity measured in perfusates collected under basal and K(+)-depolarizing conditions co-eluted with synthetic dynorphin B. Dynorphin B, GABA and dopamine levels were Ca(2+)-dependently increased by K(+)-depolarization, while 3,4-dihydroxyphenylacetic acid and homovanillic acid levels were decreased. Dopamine and its metabolites, but not dynorphin B or GABA levels, were significantly decreased after a unilateral 6-hydroxydopamine injection into the left medial forebrain bundle. In contrast, following a unilateral injection of ibotenic acid into the striatum, dynorphin B and GABA levels were decreased by > 50% in striatum and substantia nigra on the lesioned side, whereas no significant changes were observed in basal dopamine levels. The inclusion of the peptidase inhibitor captopril (50-500 microM) into the nigral perfusion medium produced a concentration-dependent increase in nigral extracellular levels of dynorphin B. In the striatum, a delayed increase in dynorphin B and GABA levels could be observed following the nigral captopril administration, but this effect was not concentration-dependent. Thus, we demonstrate that extracellular levels of dynorphin B, dopamine and GABA can simultaneously be monitored with in vivo microdialysis. Extracellular dynorphin B appears to originate from neurons, since the levels were (i) increased in a Ca(2+)-dependent manner by K(+)-depolarization, and (ii) decreased by a selective lesion of the striatum, known to contain cell bodies of dynorphin neurons in the striatonigral pathway. Furthermore, (iii) the increase in nigral dynorphin B levels by peptidase inhibition suggests the presence of clearance mechanisms for the released dynorphin peptides.
Authors:
Z B You; I Nylander; M Herrera-Marschitz; W T O'Connor; M Goiny; L Terenius
Related Documents :
9416005 - Carbon and nitrogen sources regulate delta-aminolevulinic acid and gamma-aminobutyric a...
10855775 - The techa river dosimetry system: methods for the reconstruction of internal dose.
2864395 - Succinic semialdehyde as a substrate for the formation of gamma-aminobutyric acid.
15490155 - Using lactococcus lactis for glutathione overproduction.
2302765 - Establishment of an external quality-assessment scheme for amino acid analyses: results...
19883785 - Comparison of fatty acid composition in nine organs of the sympatric antarctic teleost ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Neuroscience     Volume:  63     ISSN:  0306-4522     ISO Abbreviation:  Neuroscience     Publication Date:  1994 Nov 
Date Detail:
Created Date:  1995-04-18     Completed Date:  1995-04-18     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7605074     Medline TA:  Neuroscience     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  415-25     Citation Subset:  IM    
Affiliation:
Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Captopril / pharmacology
Chromatography
Corpus Striatum / physiology*
Dopamine / metabolism
Dynorphins / chemistry,  metabolism,  physiology*
Electrophysiology
Endorphins / chemistry,  metabolism
Extracellular Space / metabolism
Male
Microdialysis
Neural Pathways / physiology
Potassium / pharmacology*
Rats
Rats, Sprague-Dawley
Substantia Nigra / physiology*
gamma-Aminobutyric Acid / metabolism
Chemical
Reg. No./Substance:
0/Endorphins; 56-12-2/gamma-Aminobutyric Acid; 62571-86-2/Captopril; 7440-09-7/Potassium; 74913-18-1/Dynorphins; 83335-41-5/rimorphin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Presynaptic mechanisms regulating Ca2+ concentration triggering acetylcholine release at an identifi...
Next Document:  The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of do...